ICT's Product Locator: May/June 2024

Infection Control Today celebrates 30 years of covering the people, science, and challenges shaping infection prevention with another milestone: its first digital magazine, featuring outbreak analysis, biosecurity, respiratory testing, sterile processing, professional leadership, conference coverage, and more.

A 10-year NIH-funded study used Bayesian statistical modeling to examine the relationship between continuously active EOScu surfaces and HAI reduction. EOS Surfaces representatives discuss the findings, passive infection prevention, environmental recontamination, and why IPs should continue asking tough questions.

“Cutting” waste shouldn’t mean cutting people. At AHE Exchange26, David Green and Donald Sipp explored how EVS departments can improve performance by strengthening workplace culture, empowering employees, eliminating inefficient processes, and understanding EVS’s critical role in patient throughput. One case study showed bed turnaround times falling from nearly 2 hours to less than an hour, but the larger lesson wasn't simply about speed. High-performing EVS operations begin with a strong foundation.

Claryx has emerged from stealth with funding and a genomic surveillance platform designed to help hospitals identify hidden transmission chains, trace infection sources, and intervene before outbreaks grow.

During National EVS Week, appreciation matters, but partnership matters more. Environmental services professionals bring infection prevention expertise and a unique understanding of the health care environment that can help identify barriers, improve cleaning and disinfection practices, and ultimately protect patients.

Artificial intelligence can help IPs analyze surveillance data, identify patterns, improve training, and reduce repetitive work. Bassel Molaeb explains why AI literacy is becoming an important IPC competency while human validation, clinical context, and professional judgment remain essential.

How do you celebrate an infection that never happened? That's one of the unusual challenges infection preventionists share with teachers. Both can spend their careers changing outcomes they may never see. Both educate people who don't always want to listen. Both are second-guessed. Both face burnout. And both must somehow keep remembering why they started.

Bacteria have learned to evade many of our antibiotics. But what about defenses shaped by millions of years of evolution? An experimental peptide derived from the human immune protein CXCL10 targets resistant pathogens by exploiting a distinct bacterial vulnerability. The research is early, but the strategy could have implications far beyond a single drug candidate.